Norihiro Harada
Overview
Explore the profile of Norihiro Harada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
1499
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishimaki T, Sasano H, Harada S, Takeshige T, Sandhu Y, Tanabe Y, et al.
J Allergy Clin Immunol Glob
. 2025 Feb;
4(2):100410.
PMID: 39974310
Background: Asthma involves variable airflow limitation and persistent airway inflammation. Eosinophilic asthma, characterized by cytokine-mediated type 2 inflammation, is generally treated with inhaled corticosteroids. However, patients with severe asthma may...
2.
Shimada T, Maetani T, Chubachi S, Tanabe N, Asakura T, Namkoong H, et al.
J Cachexia Sarcopenia Muscle
. 2025 Jan;
16(1):e13721.
PMID: 39868664
Background: Chest computed tomography (CT) is a valuable tool for diagnosing and predicting the severity of coronavirus disease 2019 (COVID-19) and assessing extrapulmonary organs. Reduced muscle mass and visceral fat...
3.
Harada S, Kato M, Nakagome K, Sasano H, Tanabe Y, Takeshige T, et al.
Biomolecules
. 2025 Jan;
15(1).
PMID: 39858516
Diffuse interstitial lung diseases (ILD) include conditions with identifiable causes such as chronic eosinophilic pneumonia (CEP), sarcoidosis (SAR), chronic hypersensitivity pneumonitis (CHP), and connective tissue disease-associated interstitial pneumonia (CTD), as...
4.
Nagase H, Kobayashi K, Toma-Hirano M, Suzukawa M, Harada N, Masaki K, et al.
Allergol Int
. 2025 Jan;
PMID: 39848869
Background: Although randomized controlled trials (RCT) have demonstrated the efficacy of mepolizumab for asthma, they have excluded certain patient subgroups. To bridge the gap between RCT and real-world practice, the...
5.
Watase M, Shiraishi Y, Chubachi S, Tanabe N, Maetani T, Asakura T, et al.
Circ J
. 2025 Jan;
89(3):373-381.
PMID: 39828330
Background: Coronary artery calcification (CAC) detected through chest computed tomography (CT) strongly predicts cardiovascular events in asymptomatic individuals undergoing primary prevention. Few studies with limited sample sizes have investigated the...
6.
Shirai T, Hirai K, Akamatsu T, Mizumura K, Sasano H, Harada N, et al.
Allergol Int
. 2025 Jan;
PMID: 39809630
No abstract available.
7.
Konishi S, Masaki K, Shimamoto K, Ibuka Y, Goto R, Namkoong H, et al.
IJID Reg
. 2024 Dec;
14:100495.
PMID: 39717862
Objectives: We examined shifts in labor productivity and their economic ramifications among adult patients with long COVID in Japan. Methods: A total of 396 patients were categorized into three groups...
8.
Watase M, Masaki K, Chubachi S, Namkoong H, Tanaka H, Lee H, et al.
Int J Infect Dis
. 2024 Dec;
151:107322.
PMID: 39662225
No abstract available.
9.
Nomura N, Matsumoto H, Asano K, Hayashi Y, Yokoyama A, Nishimura Y, et al.
J Allergy Clin Immunol Glob
. 2024 Dec;
4(1):100364.
PMID: 39659740
Background: Sensitization to mucus plugs, and bacterial colonization may coexist and relate to a refractory phenotype during follow-up in asthma with bronchiectasis and allergic bronchopulmonary aspergillosis (ABPA). Objective: This study...
10.
Masaki K, Suzukawa M, Sasano H, Harada N, Miyazaki Y, Katsura H, et al.
Allergol Int
. 2024 Dec;
PMID: 39632158
Background: Biologics are integral in the management of severe asthma. As the effectiveness of the anti-IL-5 receptor antibody benralizumab in Japan remains elusive, this study aimed to assess its real-world...